GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » EBIT

Dis-Chem Pharmacies (JSE:DCP) EBIT : R2,009 Mil (TTM As of Aug. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies EBIT?

Dis-Chem Pharmacies's earnings before interest and taxes (EBIT) for the six months ended in Aug. 2024 was R1,073 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Aug. 2024 was R2,009 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Dis-Chem Pharmacies's annualized ROC % for the quarter that ended in Aug. 2024 was 15.50%. Dis-Chem Pharmacies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2024 was 31.35%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Dis-Chem Pharmacies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Aug. 2024 was 5.63%.


Dis-Chem Pharmacies EBIT Historical Data

The historical data trend for Dis-Chem Pharmacies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies EBIT Chart

Dis-Chem Pharmacies Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,270.89 1,285.52 1,552.71 1,787.17 1,850.81

Dis-Chem Pharmacies Semi-Annual Data
Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,016.97 770.21 914.78 936.04 1,073.05

Competitive Comparison of Dis-Chem Pharmacies's EBIT

For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dis-Chem Pharmacies's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Dis-Chem Pharmacies's EV-to-EBIT falls into.



Dis-Chem Pharmacies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Aug. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was R2,009 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dis-Chem Pharmacies  (JSE:DCP) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Dis-Chem Pharmacies's annualized ROC % for the quarter that ended in Aug. 2024 is calculated as:

ROC % (Q: Aug. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Feb. 2024 ) + Invested Capital (Q: Aug. 2024 ))/ count )
=2063.298 * ( 1 - 26.52% )/( (9703.986 + 9858.367)/ 2 )
=1516.1113704/9781.1765
=15.50 %

where

Invested Capital(Q: Feb. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=17500.986 - 6912.629 - ( 884.371 - max(0, 9183.078 - 10922.955+884.371))
=9703.986

Invested Capital(Q: Aug. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=18203.994 - 7521.215 - ( 824.412 - max(0, 9612.024 - 11425.089+824.412))
=9858.367

Note: The Operating Income data used here is two times the semi-annual (Aug. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Dis-Chem Pharmacies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Aug. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Feb. 2024  Q: Aug. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2146.094/( ( (4799.705 + max(1515.272, 0)) + (4806.957 + max(2568.449, 0)) )/ 2 )
=2146.094/( ( 6314.977 + 7375.406 )/ 2 )
=2146.094/6845.1915
=31.35 %

where Working Capital is:

Working Capital(Q: Feb. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1374.422 + 7162.558 + 240.059) - (6912.629 + 0 + 349.138)
=1515.272

Working Capital(Q: Aug. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3002.715 + 7471.534 + 0) - (7521.215 + 0 + 384.585)
=2568.449

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Aug. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Dis-Chem Pharmacies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Aug. 2024 )
=2009.082/35688.189
=5.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dis-Chem Pharmacies EBIT Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Dis-Chem Pharmacies Business Description

Traded in Other Exchanges
N/A
Address
23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.